Praxis Precision Medicines, Inc. · NASDAQ:PRAX

DeSimone Jill sold 11,600 Praxis Precision Medicines, Inc. shares (Form 4)

Traded Jun 24, 2026 · Filed Jun 26, 2026

On Jun 24, 2026, DeSimone Jill (Director) sold 11,600 Praxis Precision Medicines, Inc. shares at an average US$311.32 for US$3.61M under a trading plan, leaving 2,337 shares. Filed Jun 26, 2026 (Form 4).

Sold
11,600 shares
Price
US$311.32 average (US$301.44 to US$315.71)
Value
US$3.61M
Holding after
2,337 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 24, 2026Common StockOption exercise8,566US$44.2510,903Direct
Jun 24, 2026Common StockOption exercise3,034US$147.3013,937Direct
Jun 24, 2026Common StockSale10US$301.4413,927Direct
Jun 24, 2026Common StockSale120US$303.1313,807Direct
Jun 24, 2026Common StockSale320US$305.3113,487Direct
Jun 24, 2026Common StockSale683US$306.7712,804Direct
Jun 24, 2026Common StockSale1,240US$308.2411,564Direct
Jun 24, 2026Common StockSale999US$309.3810,565Direct
Jun 24, 2026Common StockSale1,750US$310.898,815Direct
Jun 24, 2026Common StockSale2,854US$311.915,961Direct
Jun 24, 2026Common StockSale1,004US$312.834,957Direct
Jun 24, 2026Common StockSale504US$313.664,453Direct
Jun 24, 2026Common StockSale1,279US$314.903,174Direct
Jun 24, 2026Common StockSale837US$315.712,337Direct

Source

View original at SEC

Related